Clinical Trials · NCT07213466
Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder
- Phase
- Phase 4
- Recruitment status
- Recruiting
- Sponsor
- Mayo Clinic
- Enrollment
- 100
- Start date
- Jan 2026
- Locations
- 1 site, United States
- Primary endpoint
- Describe the distribution of obesity phenotypes (hungry brain, hungry gut, emotional hunger and slow burn) in patients with BD and obesity, with the goal of identifying predominant phenotype patterns within this clinical population.